Skip to main content
N4 PHARMA PLC logo

N4 PHARMA PLC — Investor Relations & Filings

Ticker · N4P ISIN · GB00BYW8QM32 LEI · 213800I841D2RKMFK955 IL Professional, scientific and technical activities
Open in API
Filings indexed 840 across all filing types
Latest filing 2018-11-15 Investor Presentation
Country GB United Kingdom
Listing IL N4P

About N4 PHARMA PLC

https://n4pharma.com/

N4 Pharma PLC is a specialist pharmaceutical company focused on the development of Nuvec®, its proprietary silica nanoparticle delivery system. This platform technology is designed to enhance the cellular delivery and potency of nucleic acid-based treatments, such as vaccines and cancer therapies. The company's primary focus is on applying Nuvec® to enable advanced therapies for oncology and infectious diseases. N4 Pharma's business model involves developing and out-licensing its technology to pharmaceutical and biotechnology partners to improve the performance of new and existing drugs.

Recent filings

Filing Released Lang Actions
Filing of further Nuvec® patent application
Investor Presentation Classification · 1% confidence The document begins with an 'RNS Number' and is dated 15 November 2018. The content announces the 'Filing of further Nuvec® patent application' and discusses intellectual property, PCT applications, and priority dates. This is a specific regulatory announcement concerning intellectual property rights, not a general financial report (like 10-K or IR) or a management change (MANG). Since it is a formal announcement distributed via RNS (the news service of the London Stock Exchange), and it deals with intellectual property/legal matters, it fits best under the general 'Regulatory Filings' category (RNS) as a specific announcement, although 'LTR' (Legal Proceedings Report) might seem related to IP, RNS is the distribution channel identifier for this type of market news release. Given the options, RNS is the most appropriate catch-all for specific, non-financial, non-management regulatory news distributed via the exchange news service.
2018-11-15 English
Second Price Monitoring Extn
Regulatory Filings Classification · 1% confidence The document is very short (1498 characters) and contains an 'RNS Number' and explicitly states that the information is provided by 'RNS, the news service of the London Stock Exchange.' The content describes a 'Second Price Monitoring Extension' related to trading activity, which is a specific, immediate operational announcement rather than a comprehensive financial report (like 10-K or IR) or a standard corporate action announcement (like DIV or CAP). Since it is a general regulatory announcement distributed via the RNS system and does not fit precisely into the other specific categories (like DIRS, MANG, or DIV), the most appropriate classification is the general regulatory filing fallback category.
2018-11-14 English
Price Monitoring Extension
Regulatory Filings Classification · 1% confidence The document is very short (1481 characters) and contains an 'RNS Number' and mentions 'RNS, the news service of the London Stock Exchange'. The content itself is a 'Price Monitoring Extension' announcement related to trading mechanics, not a comprehensive financial report or a specific corporate action like a dividend or management change. Since it is a general regulatory announcement distributed via the RNS system and does not fit into the more specific categories (like DIV, ER, 10-K, etc.), it defaults to the general regulatory filing category.
2018-11-14 English
Second Price Monitoring Extn
Regulatory Filings Classification · 1% confidence The document is very short (1498 characters) and contains an 'RNS Number' and mentions being provided by 'RNS, the news service of the London Stock Exchange'. The content discusses a 'Second Price Monitoring Extension' for a security, which is a specific, non-standard regulatory event notification. Since it is a direct, short announcement disseminated via the RNS system and does not fit the criteria for specific financial reports (like 10-K, ER, IR) or specific corporate actions (like DIV, DIRS), the most appropriate classification is the general regulatory announcement fallback category.
2018-11-14 English
Price Monitoring Extension
Regulatory Filings Classification · 1% confidence The document is very short (1481 characters) and contains an RNS Number, indicating it is a regulatory news service announcement from the London Stock Exchange. The content specifically discusses a 'Price Monitoring Extension' for a security, which is a routine operational notice related to trading mechanisms, not a core financial report (like 10-K, ER, or IR). Since it is a specific regulatory announcement that doesn't fit into the defined categories like DVA, DIRS, or DIV, the most appropriate fallback category is 'Regulatory Filings' (RNS).
2018-11-14 English
Second Price Monitoring Extn
Regulatory Filings Classification · 1% confidence The document text contains an 'RNS Number' and explicitly states that the information is provided by 'RNS, the news service of the London Stock Exchange,' which is approved by the Financial Conduct Authority (FCA). The content describes a 'Second Price Monitoring Extension' for a security, which is a specific type of market operational announcement. This type of general, time-sensitive regulatory announcement that doesn't fit into the specific categories like 10-K, ER, or DIV is best classified under the general regulatory filing/announcement category.
2018-11-08 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.